CLASS II Device recall · Reported 1 Apr 2020 · FDA Enforcement Report

Precision Xtra Blood Glucose & Ketone Monitoring System recalled

Abbott Diabetes Care is recalling Precision Xtra Blood Glucose & Ketone Monitoring System, distributed in 32 states. The recall was initiated on 14 Nov 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesNot associated with specific model/lot numbers.
Quantity recalledN/A

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1556-2020
FDA event ID
84866
Recalling firm
Abbott Diabetes Care, Alameda, CA
Classification
Class II
Status
Terminated
Recall initiated
14 Nov 2019
FDA classified
23 Mar 2020
Reported
1 Apr 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

14 Nov 2019Recall initiated by company
23 Mar 2020Classified by FDA+130 days
1 Apr 2020Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Instructions sent in a letter or in instructions for use for disinfecting blood glucose and/or ketone meters were distributed but not cleared by the U.S. FDA, and devices were not cleared for multiple-patient use. Instructions could lead to inappropriate meter disinfection or improper handling of contaminated meters, which may cause infection or exacerbation of an existing infection.

Product as listed by the FDA

Precision Xtra Blood Glucose & Ketone Monitoring System, UDI: 00093815715023, 00093815988144

Where it was distributed

U.S.: KY, NY, TN, MA, IL, SC, VT, FL, CA, NC, MS, NJ, TX, AL, GA, OK, CT, PA, NE, ND, MT, MO, DC, ME, LA, KS, ID, OH, MN, NM, VA, IN

AlabamaCaliforniaConnecticutDistrict of ColumbiaFloridaGeorgiaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusettsMaineMinnesotaMissouriMississippiMontanaNorth CarolinaNorth Dakota

Questions about this recall

Why was it recalled?

Instructions sent in a letter or in instructions for use for disinfecting blood glucose and/or ketone meters were distributed but not cleared by the U.S. FDA, and devices were not cleared for multiple-patient use. Instructions could lead to inappropriate meter disinfection or improper handling of contaminated meters, which may cause infection or exacerbation of an existing infection.

Which lots are affected?

Not associated with specific model/lot numbers.

Where was it sold?

U.S.: KY, NY, TN, MA, IL, SC, VT, FL, CA, NC, MS, NJ, TX, AL, GA, OK, CT, PA, NE, ND, MT, MO, DC, ME, LA, KS, ID, OH, MN, NM, VA, IN

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 84866

More recalls from Abbott Diabetes Care

All 13

Other Insulin Pumps & Glucose Monitors recalls

All 459